News + Updates
Biocare Medical Acquires Empire Genomics, Expanding Molecular Portfolio to over 1 Million Biomarkers and Adding Rapid Biomarker Development to Lead Cancer Research
Velocity Clinical Research expands to UK
GHO Capital and The Vistria Group to acquire Alcami, a leading high growth CDMO, from Madison Dearborn Partners and Ampersand Capital Partners
GHO Capital Appoints Alistair Macdonald as Operating Partner
Velocity Clinical Research growth skyrockets with eight site acquisitions
RoslinCT and Lykan Bioscience Combine to Create Leading Advanced Cell Therapy CDMO
Velocity Clinical Research begins European expansion with German site acquisition
Genesis Research to Acquire Market Access Transformation, a Leading Provider of Technology-Enabled Payer Research Platforms
GHO Capital announces increased investment in Validant, alongside management, to accelerate global build-out
Sterling Pharma Solutions Expands Global API Manufacturing Capabilities with Acquisition of Novartis Facility in Ringaskiddy, Ireland
GHO Capital invests in RoslinCT, a leading cell therapy CDMO
Load more